# FDA recall D-202-2013

> **Zydus Pharmaceuticals USA Inc** · Class II · drug recall initiated 2013-03-05.

## Product

Venlafaxine Hydrochloride Tablets, 75 mg*, 100-count tablets per bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-021-01.

## Reason for recall

Failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/or chipped tablets in the bottle.

## Distribution

Nationwide.

## Key facts

- **Recall number:** D-202-2013
- **Recalling firm:** Zydus Pharmaceuticals USA Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-03-05
- **Report date:** 2013-04-03
- **Termination date:** 2015-05-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Pennington, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-202-2013

## Citation

> AI Analytics. FDA recall D-202-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-202-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*